Skip to content

Clinical trials

Epilepsy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Country / region: United States Clear all

783 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20009
20016
200214
200312
200414
200526
200632
200726
200827
200922
201031
201139
201230
201327
201428
201538
201628
201731
201843
201932
202022
202143
202242
202336
202435
202536
202632

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed436
Recruiting107
Terminated81
Unknown status42
Active, not recruiting32
Withdrawn31
Enrolling by invitation31
Not yet recruiting13
No longer available3
Available3
Suspended2
Approved for marketing2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)41
GlaxoSmithKline23
NYU Langone Health23
UCB Pharma23
Mayo Clinic18
Johns Hopkins University15
University of California, San Francisco15
Dartmouth-Hitchcock Medical Center14
Eisai Inc.14
UCB BIOSCIENCES, Inc.13

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy783
Seizures235
Epilepsies, Partial55
Drug Resistant Epilepsy43
Epilepsies, Myoclonic24
Nervous System Diseases20
Anxiety Disorders19
Migraine Disorders18
Lennox Gastaut Syndrome17
Brain Diseases16

Trials

Showing 26 to 50 of 783. Each trial links to its page on Pharma Observatory.

683 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.